1.Foxman, B and Brown, P (2003) Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infectious Disease Clinics of North America 17, 227–241.
2.Stamm, WE et al. (1989) Urinary tract infections: from pathogenesis to treatment. The Journal of Infectious Diseases 159, 400–406.
3.Yamamoto, S et al. (1997) Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. The Journal of Urology 157, 1127–1129.
4.Lau, SH et al. (2008) Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. Journal of Clinical Microbiology 46, 1076–1080.
5.Ulleryd, P et al. (2015) Colonization with Escherichia coli strains among female sex partners of men with febrile urinary tract infection. Journal of Clinical Microbiology 53, 1947–1950.
6.Johnson, JR and Clabots, C (2006) Sharing of virulent Escherichia coli clones among household members of a woman with acute cystitis. Clinical Infectious Diseases 43, e101–e108.
7.O'Neill, PM et al. (1990) The rise and fall of Escherichia coli O15 in a London teaching hospital. Journal of Medical Microbiology 33, 23–27.
8.Giesecke, J (2002) Descriptive epidemiology. In Modern Infectious Disease Epidemiology. 2nd edn. Boca Rayton, FL: CRC Press, pp. 21–26.
9.Phillips, I et al. (1988) Epidemic multiresistant Escherichia coli infection in West Lambeth Health District. The Lancet 1, 1038–1041.
10.Manges, AR et al. (2001) Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. The New England Journal of Medicine 345, 1007–1013.
11.Field, N et al. (2014) Strengthening the reporting of molecular epidemiology for infectious diseases (STROME-ID): an extension of the STROBE statement. The Lancet Infectious Diseases 14, 341–352.
12.Rosenberg, M et al. (1992) Initial testing of a novel urine culture device. Journal of Clinical Microbiology 30, 2686–2691.
13.Grabe TEB-J, M. H. (2010) Guidelines on urological infections. In: w.
14.Cinical and Laboratory Standards Insitute (2010) Performance standards for antimicrobial susceptibility testing. In Twentieth Informational Supplement. CLSI document M100-S20. Wayne, PA, USA: CLSI.
15.Clermont, O, Bonacorsi, S and Bingen, E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Applied and Environmental Microbiology 66, 4555–4558.
16.Wirth, T et al. (2006) Sex and virulence in Escherichia coli: an evolutionary perspective. Molecular Microbiology 60, 1136–1151.
17.Tamura, K et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Molecular Biology and Evolution 28, 2731–2739.
18.Pei, Y et al. (2008) Molecular characterization of enterohemorrhagic Escherichia coli O157:H7 isolates dispersed across Japan by pulsed-field gel electrophoresis and multiple-locus variable-number tandem repeat analysis. Japanese Journal of Infectious Diseases 61, 58–64.
19.Owens, RC Jr., et al. (2011) Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death. Journal of Clinical Microbiology 49, 3406–3408.
20.Manges, AR et al. (2008) Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerging Infectious Diseases 14, 1575–1583.
21.Gibreel, TM et al. (2012) Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. The Journal of Antimicrobial Chemotherapy 67, 346–356.
22.Blanco, J et al. (2011) National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. The Journal of Antimicrobial Chemotherapy 66, 2011–2021.
23.Riley, LW (2014) Pandemic lineages of extraintestinal pathogenic Escherichia coli. Clinical Microbiology and Infection 20, 380–390.
24.Yamaji, R et al. (2018) Persistent pandemic lineages of uropathogenic Escherichia coli in a college community from 1999 to 2017. Journal of Clinical Microbiology 56, e01834–17.
25.Vincent, C et al. (2010) Food reservoir for Escherichia coli causing urinary tract infections. Emerging Infectious Diseases 16, 88–95.
26.McGill, BJ et al. (2007) Species abundance distributions: moving beyond single prediction theories to integration within an ecological framework. Ecology Letters 10, 995–1015.
27.Freeman, JT et al. (2008) Community-onset genitourinary tract infection due to CTX-M-15-producing Escherichia coli among travelers to the Indian subcontinent in New Zealand. Clinical Infectious Diseases 47, 689–692.
28.Reeves, PR et al. (2011) Rates of mutation and host transmission for an Escherichia coli clone over 3 years. PLoS One 6, e26907.
29.Johnson, JR et al. (2008) Escherichia coli colonization patterns among human household members and pets, with attention to acute urinary tract infection. The Journal of Infectious Diseases 197, 218–224.
30.Umene, YD et al. (2015) Molecular epidemiological characterization of uropathogenic Escherichia coli from an outpatient urology clinic in rural Japan. Journal of Clinical Microbiology 53, 681–683.
31.Foxman, B (2010) The epidemiology of urinary tract infection. Nature Reviews Urology 7, 653–660.
32.Jackson, SL et al. (2004) Predictors of urinary tract infection after menopause: a prospective study. The American Journal of Medicine 117, 903–911.
33.Hooton, TM (2012) Clinical practice. Uncomplicated urinary tract infection. The New England Journal of Medicine 366, 1028–1037.
34.Bergeron, CR et al. (2012) Chicken as reservoir for extraintestinal pathogenic Escherichia coli in humans, Canada. Emerging Infectious Diseases 18, 415–421.
35.Manges, AR and Johnson, JR (2012) Food-borne origins of Escherichia coli causing extraintestinal infections. Clinical Infectious Diseases 55, 712–719.
36.Gupta, K et al. (2001) Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clinical Infectious Diseases 33, 89–94.
37.Hayami, H et al. (2013) Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus. Journal of Infection and Chemotherapy 19, 393–403.